Region Of Hepatocytes Research Articles

Hepatic Expression of the Mouse Angptl8 Gene Is Regulated by Insulin Through Increases in Hepatocyte Nuclear Factor-1

Angiopoietin-like proteins (ANGPTLs) are a family of proteins structurally similar to angiopoietins. ANGPTL8 is an important regulator of circulating triglyceride (TG) levels in mammals. Increasing evidence revealed an association between ANGPTL8 expression and serum lipid profiles, especially in subjects with metabolic syndrome. Several mice studies demonstrated that Angptl8 is suppressed by fasting and induced by long term refeeding, however the detailed mechanism is still unclear. In humans, ANGPTL8 is mainly expressed in the liver. Therefore, this study aims to investigate the mechanisms that control the refeeding induced increase in the hepatic Angptl8 gene expression. Methods and Results: Twenty-week-old male C57/BL6 mice were used in this study. Mice were fasted for 12h during the dark cycle and re-fed for 30, 60, 120, 240 and 360 minutes during the light cycle. Mice were euthanized after each refeeding time course and tissues were collected. We found even short refeeding times (~60 min) enhanced the expression levels of hepatic Angptl8 in mice. We cloned the mouse Angptl8 gene promoter region. Promoter deletion analyses showed that the basal promoter activity was significantly attenuated by a deletion of -309/-60 region in hepatocytes. A computational motif search revealed the presence of a potential binding motif for hepatocyte nuclear factor 1α/1β (HNF-1α/β) at -84/-68 bp of the promoter. Mutations of the HNF-1 binging site significantly decreased the promoter activity in mouse hepatoma cells (Hepa1-6) and mouse primary hepatocytes, and the promoter carrying the mutated HNF-1 site was not transactivated by co-transfected HNF-1 in a non-hepatic cell line. These findings indicated that HNF-1 was essential and critical factor for the basal expression of Angptl8 in murine liver. In fact, knockdown of Hnf-1 using siRNA method in mouse Hepa1-6 and mouse primary hepatocytes reduced Angptl8 protein levels. We also performed Electrophoretic mobility-shift assays and confirmed the direct binding of Hnf-1 to its Angptl8 promoter binding motif. To elucidate whether refeeding could enhance HNF-1, we checked the expression levels of Hnf-1 in mouse liver. Hnf-1 expression levels of both mRNA and protein were increased after short-term refeeding, paralleling the enhanced expression of the Angptl8. Moreover, insulin-stimulated primary hepatocytes showed increased expression of Angptl8 protein, but knockdown of Hnf-1 completely abolished this enhancement by insulin. Chromatin immunoprecipitation (ChIP) analyses confirmed the recruitment of endogenous Hnf-1 to the Angptl8 promoter region and it was strongly induced by insulin. Conclusion: HNF-1 plays essential role in hepatocyte-specific and refeeding-induced rapid increases in Angptl8 expression via insulin.

The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36.

Nuclear receptors (NRs) are a superfamily of transcription factors which sense hormonal signals or nutrients to regulate various biological events, including development, reproduction, and metabolism. Here, this study identifies nuclear receptor subfamily 2, group F, member 6 (NR2F6), as an important regulator of hepatic triglyceride (TG) homeostasis and causal factor in the development of non‐alcoholic fatty liver disease (NAFLD). Adeno‐associated virus (AAV)‐mediated overexpression of NR2F6 in the liver promotes TG accumulation in lean mice, while hepatic‐specific suppression of NR2F6 improves obesity‐associated hepatosteatosis, insulin resistance, and methionine and choline‐deficient (MCD) diet‐induced non‐alcoholic steatohepatitis (NASH). Mechanistically, the fatty acid translocase CD36 is identified as a transcriptional target of NR2F6 to mediate its steatotic role. NR2F6 is able to bind directly onto the CD36 promoter region in hepatocytes and increases the enrichment of nuclear receptor coactivator 1 (SRC‐1) and histone acetylation at its promoter. Of pathophysiological significance, NR2F6 is significantly upregulated in the livers of obese mice and NAFLD patients. Moreover, treatment with metformin decreases NR2F6 expression in obese mice, resulting in suppression of CD36 and reduced hepatic TG contents. Therefore, these results provide evidence for an unpredicted role of NR2F6 that contributes to liver steatosis and suggest that NR2F6 antagonists may present a therapeutic strategy for reversing or treating NAFLD/NASH pathogenesis.

Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice.

Hepatocyte estrogen receptor α (ERα) was recently recognized as a relevant molecular target for nonalcoholic fatty liver disease (NAFLD) prevention. The present study defined to what extent hepatocyte ERα could be involved in preserving metabolic homeostasis in response to a full (17β‐estradiol [E2]) or selective (selective estrogen receptor modulator [SERM]) activation. Ovariectomized mice harboring a hepatocyte‐specific ERα deletion (LERKO mice) and their wild‐type (WT) littermates were fed a high‐fat diet (HFD) and concomitantly treated with E2, tamoxifen (TAM; the most used SERM), or vehicle. As expected, both E2 and TAM prevented all HFD‐induced metabolic disorders in WT mice, and their protective effects against steatosis were abolished in LERKO mice. However, while E2 still prevented obesity and glucose intolerance in LERKO mice, hepatocyte ERα deletion also abrogated TAM‐mediated control of food intake as well as its beneficial actions on adiposity, insulin sensitivity, and glucose homeostasis, suggesting a whole‐body protective role for liver‐derived circulating factors. Moreover, unlike E2, TAM induced a rise in plasma concentration of the anorectic hepatokine growth differentiation factor 15 (Gdf15) through a transcriptional mechanism dependent on hepatocyte ERα activation. Accordingly, ERα was associated with specific binding sites in the Gdf15 regulatory region in hepatocytes from TAM‐treated mice but not under E2 treatment due to specific epigenetic modifications. Finally, all the protective effects of TAM were abolished in HFD‐fed GDF15‐knockout mice. Conclusion: We identified the selective modulation of hepatocyte ERα as a pharmacologic strategy to induce sufficient anorectic hepatokine Gdf15 to prevent experimental obesity, type 2 diabetes, and NAFLD.

Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization

The involvement of ceramide in death receptor-mediated apoptosis has been widely examined with most studies focusing on the role of ceramide generated from sphingomyelin hydrolysis. We now analyze the effect of the ceramide acyl chain length by studying tumor necrosis factor α receptor-1 (TNFR1)-mediated apoptosis in a ceramide synthase 2 (CerS2) null mouse, which cannot synthesize very-long acyl chain ceramides. CerS2 null mice were resistant to lipopolysaccharide/galactosamine-mediated fulminant hepatic failure even though TNFα secretion from macrophages was unaffected. Cultured hepatocytes were also insensitive to TNFα-mediated apoptosis. In addition, in both liver and in hepatocytes, caspase activities were not elevated, consistent with inhibition of TNFR1 pro-apoptotic signaling. In contrast, Fas receptor activation resulted in the death of CerS2 null mice. Caspase activation was blocked because of the inability of CerS2 null mice to internalize the TNFR1; whereas Fc-TNFα was internalized to a perinuclear region in hepatocytes from wild-type mice, no internalization was detected in CerS2 null mice. Our results indicate that altering the acyl chain composition of sphingolipids inhibits TNFR1 internalization and inhibits selective pro-apoptotic downstream signaling for apoptosis.

I-42 Regulation of a hepatitis C virus co-receptor claudin-1 in hepatocytes

The polarization of hepatocytes involves formation of functionally distinct sinusoidal (basolateral) and bile canalicular (apical) plasma membrane domains that are separated by tight junctions. In murine livers, integral tight junction proteins claudin-1, -2, -3, -5, -7, -8, -12, -14 which can form tight junction strands are detected together with occludin, JAM, CAR and tricellulin, and claudin-1, -2, -3 are expressed in the bile canaliculus region of hepatocytes. In the livers (mouse, rat, human), claudin-1 and -3 are expressed in the whole liver lobule, whereas claudin-2 shows a lobular gradient increasing from periportal to pericentral hepatocytes. It is reported that downregulation of claudin-1 serves as a potential marker for a poor prognosis in HCC. More recently, it is found that the claudin-1 is a hepatitis C virus co-receptor with CD81. Thus, the study of regulation of claudin-1 in hepatocytes is very important for analysis of pathogenesis of hepatitis C virus infection. We have been studied for the regulation of tight junction proteins including claudin-1 in hepatocytes in vivo and in vitro. In this lecture, we present the regulation in expression and function of hepatic claudin-1 by growth factors (EGF, TGF-beta), cytokines (IL-1beta, oncostatin M) and partial hepatectomy via distinct signal transduction pathways.

Transcriptional Coactivators CBP and p300 Cooperatively Enhance HNF-1 -Mediated Expression of the Albumin Gene in Hepatocytes

Transcriptional coactivators, CREB-binding protein (CBP) and p300, exhibit high homology in structure and similar functions. In the present study, we analyzed the function of CBP and p300 proteins as transcriptional coactivators in the expression of albumin in hepatocytes. The expression levels of CBP and p300 were high in fetal hepatocytes, but low in adult ones. Immunoprecipitation assays showed that both CBP and p300 interacted with hepatocyte nuclear factor-1alpha (HNF-1alpha) in primary hepatocytes. Furthermore, CBP and p300 were co-precipitated without HNF-1alpha. Chromatin immunoprecipitation (ChIP) assays revealed that both CBP and p300 are located in the albumin promoter region in hepatocytes. These results suggested that HNF-1alpha, CBP and p300 were incorporated into a preinitiation complex of RNA polymerase II at the albumin promoter. Luciferase reporter assays showed that CBP and p300 cooperatively triggered HNF-1alpha-mediated transcription of the albumin promoter. In addition, inhibition of CBP or p300 using small interfering RNAs (siRNAs) resulted in a reduction in albumin expression. These results suggest that both CBP and p300 are required for enhanced expression of albumin.

Subcellular localization of aldolase B.

The localization of the aldolase B isozyme was determined immunohistochemically in rat kidney and liver using a polyclonal antibody. Aldolase B was preferentially localized in a nuclear region of hepatocytes from the periportal region and was absent in those from the perivenous region. Aldolase B was also preferentially localized in the proximal tubules and was absent in other structures of the renal cortex as well as in the renal medulla. Using reflection confocal microscopy, the enzyme was preferentially localized in a nuclear position in liver and renal cells, which was similar to the cellular and intracellular location found for the gluconeogenic enzyme fructose-1,6-bisphosphatase (Sáez et al. [1996] J. Cell. Biochem. 63:453-462). Subcellular fractionation studies followed by enzyme activity assays revealed that aldolase activity was associated with subcellular particulate structures. Overall, the data suggest that different aldolase isoenzymes are needed in the glycolytic and gluconeogenic pathways.

Uptake and transport of glucagon by rat liver: evidence for transcytotic pathway

The binding of125I-glucagon to the cell surface and the pathway of intracellular transport of this hormone by rat hepatocytes in vivo were studied by light and EM autoradiography. Radiolabeled glucagon injected into the blood stream was taken up predominantly by the hepatocytes. Negligible radioactivity was found to be associated with other cell types such as endothelial or Kupffer cells. Our results indicate that at early time points after injection glucagon has been preferentially interacting with the sinusoidal domain of the hepatocytes and found to be associated with coated pits and uncoated vesicles corresponding to endosomes. At 15–20 min time intervals glucagon grains were found within hepatocyte interior. Later, at 30 min after injection glucagon grains accumulate in the Golgi-lysosomal region of hepatocyte often in close proximity to the opening of the bile canaliculi. Accordingly a portion of internalized125I-glucagon was found to be released into the bile thereby indicating that a transcytotic pathway may be involved in this peptide's clearance process.

Multistep mechanism of polarized Ca2+ wave patterns in hepatocytes.

The spatial organization of cytosolic Ca2+ (Ca2+i) signals is thought to be important for regulation of cell function. In epithelial cells, the involvement of inositol 1,4,5-trisphosphate (IP3)-mediated Ca2+ release in evoking Ca2+i signals is appreciated, but the location of IP3-sensitive Ca2+ stores and the role of Ca(2+)-induced Ca2+ release (CICR) for Ca2+ signaling are less defined. Here, we demonstrate that IP3 receptors are localized to the apical region in hepatocytes. We also show that hormone-induced Ca2+i waves propagate across the cell at a rate that depends on mobilization of Ca2+ stores that are sensitive to caffeine, ryanodine, and dantrolene, and that these agents, at concentrations that inhibit CICR, decrease the magnitude of Ca2+i signals. Furthermore, Ca2+i wave speed is not reduced in Ca(2+)-free medium. These findings suggest that Ca2+i signals in epithelial cells begin as apical-to-basal Ca2+i waves that result from sequential release of Ca2+, first from IP3-sensitive stores in the apex and then from Ca(2+)-sensitive stores distributed across the remainder of the cell.

The effect of thyroid hormone on the chromatin structure and expression of the malic enzyme gene in hepatocytes.

Malic enzyme catalyzes the NADP-dependent oxidative decarboxylation of malate to pyruvate and carbon dioxide and is involved in lipogenesis. We have investigated the effect of thyroid hormone on the chromatin structure of the malic enzyme gene in rat liver. Hypersensitivity to DNase I in the immediate 5'-flanking region was altered by T3. T3 stimulation induced hypersensitive sites at -310 base pairs (bp) and -50 bp whereas a hypersensitive site at -170 bp was thyroid hormone independent. Hypersensitive sites identified in the 3'-flanking region showed no change with T3 stimulation. We further characterized expression of the malic enzyme gene as a function of thyroidal state by localizing malic enzyme mRNA in hepatocytes using in situ hybridization histochemistry. In hypothyroid and euthyroid states, two populations of hepatocytes were seen, some with malic enzyme message and others with no detectable message. These differences in malic enzyme gene expression were most evident between groups or regions of hepatocytes. After 10 days of thyroid hormone treatment all hepatocytes demonstrated malic enzyme message. The hypersensitivity results confirm that thyroid hormone stimulation of malic enzyme synthesis occurs in part at the level of transcription, and localization of malic enzyme gene expression suggests this stimulation is accompanied by recruitment of hepatocytes. Hepatocytes may be heterogeneous in their ability to respond to thyroid hormone.